2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Melanoma
2
Vaping
1
Uterine Cervical Dysplasia
1
Smoking Cessation
1
Pain
1
Nevus, Spindle Cell
1
Nevus, Pigmented
1
Nevus, Epithelioid and Spindle Cell
1
Nevus, Blue
1
Nevus
1
Nevi and Melanomas
1
Neoplasms
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Dysplastic Nevus Syndrome
1
Cutaneous Squamous Cell Carcinoma
1
Breast Neoplasms
1
Agnosia
1
Interventions
Cyclophosphamide
45
Peripheral Blood Stem Cell Transplantation
43
fludarabine phosphate
42
Mycophenolic Acid
30
Whole-Body Irradiation
27
Cyclosporine
27
Busulfan
26
Tacrolimus
23
Antilymphocyte Serum
23
Methotrexate
20
Etoposide
20
romidepsin
19
Filgrastim
19
Melphalan
16
Radiotherapy
15
Flow Cytometry
15
Vorinostat
13
Methylprednisolone
13
Brentuximab Vedotin
13
Lenalidomide
12
Bexarotene
12
mogamulizumab
11
Psychiatric Rehabilitation
11
Bortezomib
11
Therapeutics
10
Rituximab
10
Gemcitabine
10
fludarabine
9
Polymerase Chain Reaction
9
Biopsy
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
Transdermal Patch
×
Clear all
NCT02192021
2024-08-09
MNA-D
University of Pittsburgh
Phase 1
Completed
20 enrolled